itraconazole has been researched along with Candidemia in 15 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 14 (93.33) | 24.3611 |
2020's | 1 (6.67) | 2.80 |
Authors | Studies |
---|---|
Abastabar, M; Badiee, P; Haghani, I; Mohammadi, R; Morovati, H; Noorbakhsh, M; Sharifi, M | 1 |
Bilgin, H; Cerikcioglu, N; Dogru, A; Korten, V; Ozben, B; Perk Gurun, H; Tukenmez Tigen, E | 1 |
Arsić Arsenijević, V; Delić, S; Hadnadjev, M; Janić, D; Matijašević, J; Medić, D; Minić, P; Nestorović Laban, S; Otašević, S; Savić, I; Vasiljević, Z | 1 |
Ataollahy, N; Hammarström, H; Kondori, N; Lindberg, E | 1 |
Altintop, YA; Atalay, MA; Ergul, AB; Koc, AN | 1 |
Antoniadou, E; Belesiotou, E; Dimopoulos, G; Giamarellos-Bourboulis, EJ; Katsenos, C; Mandragos, K; Maraki, S; Pistiki, A; Routsi, C; Samonis, G; Solomonidi, N; Stamou, A; Tasioudis, C; Vlachogianni, G | 1 |
Chander, J; Gombar, S; Sidhu, SK; Singla, N | 1 |
Arakawa, S; Fujisawa, M; Hayama, B; Iwata, K; Jikimoto, T; Ohji, G; Osawa, K; Shigemura, K; Yoshida, H | 1 |
Horiuchi, C; Ikeda, T; Iwanaga, N; Kamiya, C; Katsuragi, S; Kobayashi, Y; Miyoshi, T; Neki, R; Sata, M; Tanaka, H; Yamanaka, K; Yamashita, Y; Yoshimatsu, J | 1 |
Hsueh, PR; Wang, H; Xu, YC | 1 |
Banjara, N; Florescu, DF; Gomes-Neto, JC; Hallen-Adams, HE; Iwen, PC; Mercer, DF; Suhr, MJ | 1 |
Hagihara, M; Hasegawa, T; Kasai, H; Kato, T; Mikamo, H; Umemura, T | 1 |
Meurman, JH; Pärnänen, P; Samaranayake, LP; Seneviratne, CJ; Vaara, M; Wong, SS; Yuen, KY | 1 |
Chang, HH; Ha, YE; Han, SH; Joo, EJ; Jung, SI; Kim, SW; Park, KH; Peck, KR | 1 |
Baez, AA; Bonfietti, LX; Castro e Silva, DM; Martins, MA; Melhem, MS; Pukinskas, SR; Purisco, SU; Szeszs, MW | 1 |
1 review(s) available for itraconazole and Candidemia
Article | Year |
---|---|
Epidemiology of candidemia and antifungal susceptibility in invasive Candida species in the Asia-Pacific region.
Topics: Anidulafungin; Antifungal Agents; Asia; Azoles; Candida; Candida albicans; Candida glabrata; Candida tropicalis; Candidemia; Candidiasis; Candidiasis, Invasive; Drug Resistance, Fungal; Echinocandins; Fluconazole; Humans; Incidence; Itraconazole; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Phenotype; Prevalence; Voriconazole | 2016 |
14 other study(ies) available for itraconazole and Candidemia
Article | Year |
---|---|
A 3-year study of
Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Candida; Candidemia; Candidiasis; Drug Resistance, Fungal; Fluconazole; Humans; Itraconazole; Microbial Sensitivity Tests; Neoplasms | 2023 |
Risk factors, characteristics, and outcomes of candidemia in an adult intensive care unit in Turkey.
Topics: Aged; Anti-Bacterial Agents; Antifungal Agents; Candida; Candidemia; Central Venous Catheters; Female; Humans; Intensive Care Units; Itraconazole; Length of Stay; Male; Microbial Sensitivity Tests; Middle Aged; Organ Dysfunction Scores; Parenteral Nutrition; Renal Insufficiency; Retrospective Studies; Risk Factors; Turkey | 2017 |
Candida bloodstream infections in Serbia: First multicentre report of a national prospective observational survey in intensive care units.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Azoles; Candida; Candidemia; Child; Child, Preschool; Female; Flucytosine; Humans; Incidence; Infant; Infant, Newborn; Intensive Care Units; Itraconazole; Male; Microbial Sensitivity Tests; Middle Aged; Prospective Studies; Serbia; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Surveys and Questionnaires; Young Adult | 2018 |
Species distribution and antifungal drug susceptibilities of yeasts isolated from the blood samples of patients with candidemia.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amphotericin B; Anidulafungin; Antifungal Agents; Candida; Candida albicans; Candida glabrata; Candida parapsilosis; Candidemia; Caspofungin; Child; Child, Preschool; Female; Fluconazole; Flucytosine; Humans; Itraconazole; Male; Micafungin; Microbial Sensitivity Tests; Middle Aged; Triazoles; Voriconazole; Young Adult | 2019 |
Evaluation of Candida colonization and use of the Candida Colonization Index in a paediatric Intensive Care Unit: a prospective observational study.
Topics: Adolescent; Amphotericin B; Antifungal Agents; Candida; Candidemia; Caspofungin; Child; Child, Preschool; Disease Susceptibility; Feasibility Studies; Female; Fluconazole; Humans; Infant; Intensive Care Units, Pediatric; Itraconazole; Male; Microbial Sensitivity Tests; Organ Specificity; Prospective Studies; Sensitivity and Specificity; Voriconazole | 2019 |
Susceptibility profiles and clinical efficacy of antifungals against candida bloodstream isolates from critically ill patients: Focus on intravenous itraconazole.
Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Candida; Candidemia; Critical Illness; Female; Humans; Itraconazole; Male; Microbial Sensitivity Tests; Middle Aged; Prospective Studies; Treatment Outcome | 2019 |
Epidemiology of Candida blood stream infections: experience of a tertiary care centre in North India.
Topics: Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Candida; Candidemia; Drug Resistance, Fungal; Fluconazole; Humans; India; Itraconazole; Microbial Sensitivity Tests; Middle Aged; Prevalence; Retrospective Studies; Risk Factors; Tertiary Care Centers | 2013 |
Comparison of the clinical risk factors between Candida albicans and Candida non-albicans species for bloodstream infection.
Topics: Aged; Aged, 80 and over; Antifungal Agents; Antineoplastic Agents; Candida; Candida albicans; Candidemia; Cardiovascular Diseases; Drug Resistance, Fungal; Female; Fluconazole; Hospitals, University; Hospitals, Urban; Humans; Itraconazole; Japan; Male; Microbial Sensitivity Tests; Middle Aged; Neoplasms; Retrospective Studies; Risk Factors | 2014 |
Antifungal susceptibility of Candida isolates at one institution.
Topics: Amphotericin B; Antifungal Agents; Candida; Candida albicans; Candida glabrata; Candida tropicalis; Candidemia; Drug Resistance, Fungal; Echinocandins; Fluconazole; Flucytosine; Health Facilities; Humans; Itraconazole; Japan; Lipopeptides; Micafungin; Time Factors; Voriconazole | 2014 |
Epidemiological investigation of Candida species causing bloodstream infection in paediatric small bowel transplant recipients.
Topics: Adolescent; Adult; Amphotericin B; Antifungal Agents; Candida; Candidemia; Caspofungin; DNA, Fungal; Drug Resistance, Fungal; Echinocandins; Female; Humans; Intestine, Small; Itraconazole; Lipopeptides; Male; Multilocus Sequence Typing; Sequence Analysis, DNA; Transplant Recipients; Triazoles; Young Adult | 2017 |
Pharmacokinetic-pharmacodynamic study of itraconazole in patients with fungal infections in intensive care units.
Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Candida; Candidemia; Candidiasis; Female; Hospitals, University; Humans; Intensive Care Units; Itraconazole; Japan; Male; Middle Aged; Treatment Failure; Treatment Outcome | 2011 |
Antifungal susceptibility and virulence attributes of bloodstream isolates of Candida from Hong Kong and Finland.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidemia; Caspofungin; Drug Resistance, Fungal; Echinocandins; Finland; Fluconazole; Flucytosine; Hemolysin Proteins; Hong Kong; Humans; Itraconazole; Ketoconazole; Lipopeptides; Microbial Sensitivity Tests; Peptide Hydrolases; Pyrimidines; Triazoles; Virulence Factors; Voriconazole | 2011 |
Impact of first-line antifungal agents on the outcomes and costs of candidemia.
Topics: Adult; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Candidemia; Deoxycholic Acid; Drug Combinations; Female; Humans; Itraconazole; Male; Middle Aged; Retrospective Studies | 2012 |
Comparison of the broth microdilution (BMD) method of the European Committee on Antimicrobial Susceptibility Testing and the Clinical Laboratory Standards Institute BMD method for non-Candida albicans and non-C. tropicalis bloodstream isolates from eleven
Topics: Amphotericin B; Antifungal Agents; Blood; Brazil; Candida; Candidemia; DNA, Fungal; Drug Resistance, Fungal; Fluconazole; Humans; Itraconazole; Microbial Sensitivity Tests; Pichia; Pyrimidines; Tertiary Care Centers; Triazoles; Voriconazole | 2012 |